Eclipse Regenesis
Other, 1490 Obrien Dr Ste C, Menlo Park, California, 94025, United States, 1-10 Employees
Who is ECLIPSE REGENESIS
The first tissue regeneration therapy for Short Bowel Syndrome (SBS). SBS is a devastating condition where the small intestine is too short to absorb sufficient nutrients to sustain a pat...
Read More
-
Headquarters: 1490 Obrien Dr Ste C, Menlo Park, California, 94025, United States
-
Date Founded: 2017
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
-
CEO:
Andre Bessette
Email
Phone
SIC Code: 
Does something look wrong? Fix it. | View contact records from ECLIPSE REGENESIS
Eclipse Regenesis Org Chart and Mapping
Similar Companies to Eclipse Regenesis
Prima Medical
-
11-50
-
$ 1 Million to 5 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Eclipse Regenesis
Answer: Eclipse Regenesis's headquarters are located at 1490 Obrien Dr Ste C, Menlo Park, California, 94025, United States
Answer: Eclipse Regenesis's official website is https://eclipseregenesis.com
Answer: Eclipse Regenesis's revenue is Under $1 Million
Answer: Eclipse Regenesis's SIC: 3829
Answer: Eclipse Regenesis's NAICS: 339112
Answer: Eclipse Regenesis has 1-10 employees
Answer: Eclipse Regenesis is in Other
Answer: Eclipse Regenesis top competitors include: Prima Medical
Answer: Eclipse Regenesis contact info: Phone number: Website: https://eclipseregenesis.com
Answer: The first tissue regeneration therapy for Short Bowel Syndrome (SBS). SBS is a devastating condition where the small intestine is too short to absorb sufficient nutrients to sustain a patient. It results from the surgical removal of a large portion of the small intestine due to a congenital or acquired defect. The Eclipse XL1 therapy is designed to grow 2-3x longer, healthy intestine within 2-3 weeks using an entirely mechanical, repeatable approach. The new tissue has been shown to absorb nutrients and function the same as, or better than, healthy intestinal tissue. The Eclipse XL 1 device is an investigational product and limited by Federal law to investigational use. It is not currently available for commercial sale in the U.S. or any other region. Eclipse Regenesis and Eclipse XL1 are registered trademarks of Eclipse Regenesis, Inc.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month